Arkolith/Insider Trading/CPHI/Form 4

Li Zhilin

CEO & Interim CFO, Director, 10% OwnerCHINA PHARMA HOLDINGS, INC. (CPHI) · full profile →Form 4 · filed Sep 13, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 9, 2021Grant(A)1.8M$0.67$1.2M13.8M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-21-047830) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML